Login to Your Account



Pharma: Clinic Roundup


Tuesday, July 9, 2013
• Asubio Pharmaceuticals Inc., of Paramus, N.J., expanded enrollment for its ASCENT-ASCI (Asubio Spinal Cord Early Neuro-recovery Treatment for Acute Spinal Cord Injury) trial to include AIS A, B and C injury to the cervical spine.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription